• An Bras Dermatol · Jul 2009

    An estimate of the cost of treating melanoma disease in the state of Sao Paulo - Brazil.

    • Reynaldo José Sant Anna Pereira de Souza, Adriana Prest Mattedi, Marcelo Lacerda Rezende, Marcelo de Paula Corrêa, and Etiene Marques Duarte.
    • Fundação SobecCan, Hospital do Câncer de Ribeirão Preto, SP, Brazil. reynaldojsantanna@gmail.com
    • An Bras Dermatol. 2009 Jul 1;84(3):237-43.

    ObjectiveThe purpose of this study was to estimate the direct cost of diagnosing and treating melanoma disease in Sao Paulo (Brazil) between the years 2000 and 2007.MethodsThe project Clinical Practice Guidelines in Oncology was used, adapted to the proceedings of SOBECCan Foundation. The estimated costs were based on the values of the medical treatment paid by the Brazilian National Health System (SUS) and private healthcare insurance companies (PHIC) in 2007.ResultsThe total cost was estimated in R$33,012,725.1 (SUS) and R$76,133,662.8 (PHIC). Stages 0, I and II comprised about 4.2% (SUS) and 1.3% (PHIC) of the total cost; stages III and IV amounted to 95.8% and 98.7% of the total cost, respectively.ConclusionThe diagnosis of malignant melanoma in its initial stages reduces treatment costs generating considerable savings of resources for both National Health System and private healthcare insurance companies.

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,704,841 articles already indexed!

We guarantee your privacy. Your email address will not be shared.